Detection of Circulating Tumor Cell Subpopulations in Patients with Head and Neck Squamous Cell Carcinoma (HNSCC)

被引:34
|
作者
Weller, Patrick [1 ]
Nel, Ivonne [2 ]
Hassenkamp, Philipp [1 ,2 ]
Gauler, Thomas [2 ]
Schlueter, Anke [1 ]
Lang, Stephan [1 ]
Dountsop, Paulette [3 ]
Hoffmann, Andreas-Claudius [2 ]
Lehnerdt, Goetz [1 ,4 ]
机构
[1] Univ Duisburg Essen, Univ Hosp Essen, Dept Otorhinolaryngol, Essen, Germany
[2] Univ Duisburg Essen, West German Canc Ctr, Dept Med Oncol, Essen, Germany
[3] Evangel Krankenhaus Duesseldorf, Dept Otorhinolaryngol, Dusseldorf, Germany
[4] St Anna Klin, Dept Otorhinolaryngol, Wuppertal, Germany
来源
PLOS ONE | 2014年 / 9卷 / 12期
关键词
MESENCHYMAL STEM-CELLS; LOCALLY ADVANCED HEAD; PERIPHERAL-BLOOD; BONE-MARROW; CANCER; METASTASIS; EXPRESSION;
D O I
10.1371/journal.pone.0113706
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: Since image based diagnostic tools fail to detect early metastasis in head and neck squamous cell carcinoma (HNSCC) it is crucial to develop minimal invasive diagnostic methods. A promising approach is to identify and characterize circulating tumor cells (CTC) in the peripheral blood of HNSCC patients. In this pilot study, we assessed which non-hematopoietic cell types are identifiable and whether their numbers differ in pre- and postoperative blood samples. Methods: 20 ml citrated peripheral blood was taken from 10 HNSCC patients before and after curative resection. CTC were enriched using density gradient centrifugation. CTC presence was verified by multi-immunofluorescence staining against cytokeratin (CK; epithelial), N-cadherin (mesenchymal); CD133 (stem-cell), CD45 (hematopoietic) and DAPI (nucleus). Individual cell type profiles were analyzed. Results: We were able to detect cells with epithelial properties like CK+/N-cadherin-/CD45- and CK+/CD133-/CD45- as well as cells with mesenchymal features such as N-cadherin+/CK-/CD45- and cells with both characteristics like N-cadherin+/CK+/CD45-. We also observed cells showing stem cell-like features like CD133+/CK-/CD45- and cells with both epithelial and stem cell-like features such as CD133+/CK+/CD45-. The number of CK positive cells (p=0.002), N-cadherin positive cells (p=0.002) and CD133 positive cells (p=0.01) decreased significantly after resection. Kaplan-Meier test showed that the survival was significantly shorter when N-cadherin+ cells were present after resection (p=0.04; 474 vs. 235 days; [HR]=3.1). Conclusions: This is - to the best of our knowledge- the first pilot study identifying different CTC populations in peripheral blood of HNSCC patients and showing that these individual cell type profiles may have distinct clinical implications.
引用
收藏
页数:14
相关论文
共 50 条
  • [31] Circulating tumor DNA kinetics in recurrent/metastatic head & neck squamous cell cancer (R/M HNSCC) patients
    Taylor, K.
    Zou, J.
    Burgener, J.
    Zhao, E.
    Torti, D.
    Oliva, M.
    Spreafico, A.
    Hansen, A. R.
    Jang, R.
    McDade, S. S.
    Coyle, V. M.
    Lawler, M.
    Elimova, E.
    Bratman, S. V.
    Siu, L. L.
    ANNALS OF ONCOLOGY, 2021, 32 : S796 - S797
  • [32] CIRCULATING TUMOR CELLS (CTCS) IN PATIENTS WITH RECURRENT/METASTATIC HEAD AND NECK SQUAMOUS CELL CARCINOMA (HNSCC): FREQUENCY, CLINICAL SIGNIFICANCE AND EGFR EXPRESSION
    Grisanti, S.
    Almici, C.
    Consoli, F.
    Verardi, R.
    Buglione, M.
    Ferrari, V. D.
    Bolzoni-Villaret, A.
    Nicolai, P.
    Magrini, S. M.
    Simoncini, E.
    ANNALS OF ONCOLOGY, 2012, 23 : 338 - 338
  • [33] Histopathologic Determinants of Tumor-Immune Microenvironment in Head and Neck Squamous Cell Carcinoma (HNSCC)
    de la Iglesia, Janis
    Hernandez-Prera, Juan
    Masannat, Jude
    Wenig, Bruce
    Slebos, Robbert
    Chung, Christine
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 1189 - 1189
  • [34] Histopathologic Determinants of Tumor-Immune Microenvironment in Head and Neck Squamous Cell Carcinoma (HNSCC)
    de la Iglesia, Janis
    Hernandez-Prera, Juan
    Masannat, Jude
    Wenig, Bruce
    Slebos, Robbert
    Chung, Christine
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 1189 - 1189
  • [35] Circulating tumor cell analysis in locally advanced and metastatic squamous cell carcinoma of the head and neck
    Harris, Ethan J.
    Huang, Julian
    Carroll, Erin
    Lowe, Alarice C.
    Chau, Nicole G.
    Rabinowits, Guilherme
    Haddad, Robert
    Hanna, Glenn J.
    Haddad, Tyler
    Sanborn, Matthew
    Kacew, Alec
    Lorch, Jochen
    LARYNGOSCOPE INVESTIGATIVE OTOLARYNGOLOGY, 2020, 5 (06): : 1063 - 1069
  • [36] Novel Predictive Biomarkers in the Head and Neck Squamous Cell Carcinoma (HNSCC)
    Miniuk, Magdalena
    Reszec-Gielazyn, Joanna
    Bortnik, Piotr
    Borsukiewicz, Agata
    Mroczek, Aleksandra
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (19)
  • [37] LncRNAs as prognostic biomarkers in head and neck squamous cell carcinoma (HNSCC)
    Chaudhary, Ritu
    Wang, Xuefeng
    Cao, Biwei
    Gimbrone, Nicholas T.
    Slebos, Robbert J. C.
    Chung, Christine H.
    CANCER RESEARCH, 2019, 79 (13)
  • [38] Differential expression profiling of head and neck squamous cell carcinoma (HNSCC)
    F Lemaire
    R Millon
    J Young
    A Cromer
    C Wasylyk
    I Schultz
    D Muller
    P Marchal
    C Zhao
    D Melle
    L Bracco
    J Abecassis
    B Wasylyk
    British Journal of Cancer, 2003, 89 : 1940 - 1949
  • [39] Tumour stem cells in head and neck squamous cell carcinoma (HNSCC)
    Goldie, S. J.
    Watt, F. M.
    Price, R.
    ORAL ONCOLOGY, 2009, : 72 - 72
  • [40] PTEN and cetuximab resistance in head and neck squamous cell carcinoma (HNSCC).
    Da Costa, Alexandre Andre B. A.
    Costa, Felipe D'Almeida
    De Oliveira, Andrea Cruz Ferraz
    Stecca, Carlos
    Oliveira, Audrey
    Alves, Ana Caroline Fonseca
    Camandaroba, Marcos Pedro Guedes
    Araujo, Daniel Vilarim
    Machado, Larissa
    De Lima, Vladmir Claudio Cordeiro
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35